Interestingly, TGF-β, but not ovarian cancer conditioned medium, also promotes Il17a expression in CD4+IL-17A+ TALs, suggesting that TGFβ might be promoting IL-17A+Foxp3+ cells while the tumour microenvironment promotes exTh17 Foxp3+ T cells. The gene discussed is CD4; the disease is ovarian cancer.